Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS

Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS Merz Aesthetics is launching Ultherapy PRIME® across Europe, the Middle East, and Africa, marking an exciting evolution of the non-invasive Ultherapy® skin lifting technology. This advanced version of Ultherapy® promises…

Read MoreCongress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS

Innovation by USound Enables Advanced Health Monitoring in TWS Earphones

Innovation by USound Enables Advanced Health Monitoring in TWS Earphones USound, a global leader in Micro Electronic Mechanical Systems (MEMS) speakers, has unveiled a groundbreaking innovation that will enable true wireless systems (TWS) earphones to feature advanced health monitoring capabilities…

Read MoreInnovation by USound Enables Advanced Health Monitoring in TWS Earphones

Vaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA

Vaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA Vaxxas, a clinical-stage biotechnology company focused on commercializing its innovative high-density microarray patch (HD-MAP) vaccination platform, today announced that the Coalition for Epidemic Preparedness Innovations (CEPI) has approved the…

Read MoreVaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA

Collaboration Announced Between Simulations Plus and ETC for GastroPlus®

Collaboration Announced Between Simulations Plus and ETC for GastroPlus® Simulations Plus, Inc. (Nasdaq: SLP), a leader in biosimulation and performance solutions for the biopharma industry, has entered into an exciting new collaboration with the Enabling Technologies Consortium (ETC). This funded…

Read MoreCollaboration Announced Between Simulations Plus and ETC for GastroPlus®

Pancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment

Pancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment BPGbio, Inc., a clinical-stage biopharma company specializing in mitochondrial biology and protein homeostasis, today revealed new findings in pancreatic cancer subtyping from its long-term Project Survival® (NCT2781012)…

Read MorePancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment

VSee Health Announces $935K Contracts with Leading Medical Device Manufacturers

VSee Health Announces $935K Contracts with Leading Medical Device Manufacturers VSee Health, Inc. (Nasdaq: VSEE), a leading provider of comprehensive digital health services and tailored telehealth workflows, has secured contracts totaling approximately $935,000 with several prominent medical technology solution companies.…

Read MoreVSee Health Announces $935K Contracts with Leading Medical Device Manufacturers

Charles River Expands Apollo™ Ecosystem with Custom Client Experiences

Charles River Expands Apollo™ Ecosystem with Custom Client Experiences Charles River Laboratories International, Inc. (NYSE: CRL) today introduced Apollo™ for CRADL®, a secure cloud-based platform designed to enhance its vivarium rental services. This digital platform connects clients effortlessly with the…

Read MoreCharles River Expands Apollo™ Ecosystem with Custom Client Experiences